We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Current role of FDG PET/CT in lymphoma.
- Authors
Kostakoglu, Lale; Cheson, Bruce
- Abstract
The management approach in Hodgkin's (HL) and high-grade non-Hodgkin's lymphomas (NHL) has shifted towards reducing the toxicity and long-term adverse effects associated with treatment while maintaining favorable outcomes in low-risk patients. The success of an individualized treatment strategy depends largely on accurate diagnostic tests both at staging and during therapy. In this regard, positron emission tomography (PET) using fluorodeoxyglucose (FDG) with computed tomography (CT) has proved effective as a metabolic imaging tool with compelling evidence supporting its superiority over conventional modalities, particularly in staging and early evaluation of response. Eventually, this modality was integrated into the routine staging and restaging algorithm of lymphomas. This review will summarize the data on the proven and potential utility of PET/CT imaging for staging, response assessment, and restaging, describing current limitations of this imaging modality.
- Subjects
HODGKIN'S disease; LYMPHOMAS; POSITRON emission tomography; TOMOGRAPHY; RETICULOENDOTHELIAL granulomas; MEDICAL imaging systems; LYMPHOPROLIFERATIVE disorders; RADIONUCLIDE imaging
- Publication
European Journal of Nuclear Medicine & Molecular Imaging, 2014, Vol 41, Issue 5, p1004
- ISSN
1619-7070
- Publication type
Article
- DOI
10.1007/s00259-013-2686-2